Latest News of AYTU
Aytu BioPharma Inc (AYTU) Q1 2025 Earnings Call Highlights: A Historic Quarter with Positive ...
By Yahoo! Finance |
1 week ago
The company is expanding its ADHD franchise reach through various strategies like leveraging unique distributors, RS Connect network pharmacies, and nonpersonal promotion tactics. Pediatric scripts ha...
AYTU Stock Price | Aytu BioPharma Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch
By MarketWatch |
1 week ago
Aytu Biopharma, Inc. is a specialty pharmaceutical company focused on acquiring and commercializing novel products. It operates in Rx and Consumer Health segments, offering a range of prescription and...
Aytu BioPharma Names Ryan Selhorn as CFO
By MarketWatch |
1 week ago
Ryan Selhorn has been appointed as Aytu BioPharma's CFO, treasurer, and corporate secretary, effective Nov. 11, succeeding Mark Oki. Selhorn previously held various finance roles and will earn an annu...
-
Q4 2024 Aytu Biopharma Inc Earnings Call
By Yahoo! Finance | 1 month agoJoshua Disbrow, CEO of Aytu Biopharma, discusses the fiscal 2024 Q4 earnings call with positive results. Focus on Rx business growth, pediatric portfolio improvement, and leveraging RxConnect for futu...
-
Analysts Expect Breakeven For Aytu BioPharma, Inc. (NASDAQ:AYTU) Before Long
By Yahoo! Finance | 2 months agoAytu BioPharma, Inc. is a pharmaceutical company approaching breakeven with potential for profitability in 2025. Analysts predict a 96% growth rate is needed for profitability, noting the company's hi...
-
It's Unlikely That The CEO Of Aytu BioPharma, Inc. (NASDAQ:AYTU) Will See A Huge Pay Rise This Year
By Yahoo! Finance | 5 months agoAytu BioPharma's EPS increased by 71% in three years, but shareholders experienced a 97% loss. Shareholders can address concerns at the upcoming AGM on June 26, including CEO compensation....